Return to Normal Menses After Depo-Provera Discontinuation
After stopping Depo-Provera, expect normal menstrual cycles to resume between 4 to 9 months after the last injection, with ovulation typically returning when medroxyprogesterone acetate (MPA) levels fall below 0.1 ng/mL.
Evidence-Based Timeline
The most authoritative guideline data indicates a wide variation in time to ovulation after the last DMPA injection, with the majority ranging from 15 to 49 weeks (approximately 4-12 months) from the last injection 1. This represents the most comprehensive systematic review of 12 studies evaluating return to fertility.
Key Timeframes to Counsel Patients:
- Median time to conception: 5.5 months plus the 15-week duration of the last injection effect = approximately 9 months total 2
- Ovulation resumption: Occurs when MPA serum levels drop below 0.1 ng/mL 3
- MPA detection: Can persist in serum for up to 9 months after a single 150 mg injection 3
- Return to fertility: No difference between 1-year and 2-year non-conception rates compared to IUD users, indicating eventual full fertility restoration 2
Pharmacokinetic Explanation
The delay is directly related to MPA clearance from the body. After a 150 mg injection, MPA plateaus at approximately 1.0 ng/mL for about 3 months, then gradually declines 3. Ovulation is suppressed as long as MPA levels remain above 0.1 ng/mL. When levels fall below 0.5 ng/mL (around 4 months post-injection), estradiol levels begin rising, signaling the return of ovarian function 3.
Important Clinical Considerations
Individual Variation
There is substantial individual variation in return to fertility. Some women may ovulate earlier, while others experience longer delays. The median of 9 months should be presented as an average, not a guarantee 2.
Duration of Use Does Not Matter
Prolonged use of DMPA does not increase the delay before conception 2. A woman who used DMPA for 5 years will have the same expected return to fertility as one who used it for 1 year.
Parity Does Not Affect Return
Never-pregnant women have similar fertility return patterns as women who have previously been pregnant 2.
Comparison to Other Injectables
For context, norethisterone enanthate (NET-EN) shows significantly faster return to ovulation at 2.6 months compared to DMPA's 5.5 months 4, highlighting DMPA's uniquely prolonged effect.
Counseling Points
Before initiating DMPA, patients must understand that this delayed return to fertility is an expected characteristic of the medication, not a complication 5. The 2014 Pediatrics guideline specifically notes this as "typically 9 to 18 months" for return to fertility 5.
What Patients Should Expect:
- Amenorrhea during use is common and normal
- After stopping, irregular bleeding may occur before regular cycles resume
- Fertility returns gradually as hormone levels normalize
- Plan accordingly if pregnancy is desired after discontinuation
Common Pitfall to Avoid
Do not reassure patients that fertility will return "immediately" or "within a few months" after stopping DMPA. The evidence clearly shows a median 9-month delay from the last injection to conception, which is significantly longer than other reversible contraceptive methods. This information is critical for informed consent and family planning decisions.